CD4 and neoplasm: The Rosenberg group demonstrated dramatic tumor regression in a metastatic cholangiocarcinoma patient treated with a personalized adoptive cell transfer, where over 95% of autologous T cells consisted of CD4+ T cells that recognized a single HLA class-II-restricted neoantigen (37).